Ronald K. Mayfield

Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity

Louis J. Aronne, Naveed Sattar, Deborah B. Horn et al. · JAMA · 2023 · 709 citations · Full text

Agriculture, Pharmacotherapy, Clinical Pharmacology +16

Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial

Stefano Del Prato, Steven E. Kahn, Imre Pávó et al. · The Lancet · 2021 · 642 citations

Medicine, Pharmacology, Pharmacotherapy +16

Epigenomic profiling reveals an association between persistence of DNA methylation and metabolic memory in the DCCT/EDIC type 1 diabetes cohort

Zhuo Chen, Andrew D. Paterson, John M. Lachin et al. · Proceedings of the National Academy of Sciences · 2016 · 240 citations · Full text

Life Sciences, Genetics, Molecular Biology +15

Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis

Peter Rossing, Stefan D. Anker, Gerasimos Filippatos et al. · Diabetes Care · 2022 · 199 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Effect of Metabolic Control on Lipid, Lipoprotein, and Apolipoprotein Levels in 55 Insulin-dependent Diabetic Patients: A Longitudinal Study

Maria F. Lopes‐Virella, Hulda J. Wohltmann, Ronald K. Mayfield et al. · Diabetes · 1983 · 124 citations

Life Sciences, Endocrinology, Diabetology +15